Oral passive IgY-based immunotherapeutics

Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera.

In an attempt to prepare egg yolk immunoglobulin (IgY) to treat and prevent cholera, hens were immunized by a mixture of heat- or formalin-killed Vibrio cholerae O1 and O139 organisms, or by the recombinant cholera toxin B subunit (CTB). The IgYs were partially purified from egg yolk and orally administered to suckling mice before or after challenge with live O1 or O139 cells. The anti-O1 and O...

Peptide-Based Immunotherapeutics and Vaccines

1 Departamento de Microbiologı́a I, Inmunologı́a, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain 2 Inmunotek SL, Alcalá de Henares, 28805 Madrid, Spain 3 School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK 4ATR, LLC, Worcester, MA 01606, USA 5Department of Mycobacteriology, National Institute of Infectious Diseases, Higashi-Murayama, Tokyo 189-0002, Japan

Gene-based vaccines and immunotherapeutics.

DNA vaccines, comprised of plasmid DNA encoding proteins from pathogens, allergens, and tumors, are being evaluated as prophylactic vaccines and therapeutic treatments for infectious diseases, allergies, and cancer; plasmids encoding normal human proteins are likewise being tested as vaccines and treatments for autoimmune diseases. Examples of in vivo prophylaxis and immunotherapy, based on dif...

Alzheimer's disease: molecularly based immunotherapeutics.

Editorial Peptide-Based Immunotherapeutics and Vaccines

1 Departamento de Microbiologı́a I, Inmunologı́a, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain 2 Inmunotek SL, Alcalá de Henares, 28805 Madrid, Spain 3 School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK 4ATR, LLC, Worcester, MA 01606, USA 5Department of Mycobacteriology, National Institute of Infectious Diseases, Higashi-Murayama, Tokyo 189-0002, Japan